- Home
- NTWK vs DXR Comparison
NTWK vs DXR Comparison
Compare NTWK & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- DXR
- Stock Information
- Founded
- NTWK 1997
- DXR 1970
- Country
- NTWK United States
- DXR United States
- Employees
- NTWK N/A
- DXR N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- DXR Medical/Dental Instruments
- Sector
- NTWK Technology
- DXR Health Care
- Exchange
- NTWK Nasdaq
- DXR Nasdaq
- Market Cap
- NTWK 33.8M
- DXR 36.4M
- IPO Year
- NTWK 1998
- DXR N/A
- Fundamental
- Price
- NTWK $3.20
- DXR $9.63
- Analyst Decision
- NTWK
- DXR Strong Buy
- Analyst Count
- NTWK 0
- DXR 1
- Target Price
- NTWK N/A
- DXR $25.00
- AVG Volume (30 Days)
- NTWK 10.9K
- DXR 5.6K
- Earning Date
- NTWK 05-14-2025
- DXR 01-01-0001
- Dividend Yield
- NTWK N/A
- DXR N/A
- EPS Growth
- NTWK N/A
- DXR 86.16
- EPS
- NTWK 0.02
- DXR 0.11
- Revenue
- NTWK $64,127,568.00
- DXR $119,714.00
- Revenue This Year
- NTWK N/A
- DXR N/A
- Revenue Next Year
- NTWK N/A
- DXR N/A
- P/E Ratio
- NTWK $145.53
- DXR $84.18
- Revenue Growth
- NTWK 9.18
- DXR N/A
- 52 Week Low
- NTWK $2.14
- DXR $6.55
- 52 Week High
- NTWK $3.34
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- NTWK 76.52
- DXR 66.09
- Support Level
- NTWK $2.83
- DXR $8.68
- Resistance Level
- NTWK $2.98
- DXR $9.03
- Average True Range (ATR)
- NTWK 0.09
- DXR 0.46
- MACD
- NTWK 0.02
- DXR 0.02
- Stochastic Oscillator
- NTWK 100.00
- DXR 100.00
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.